🇺🇸 FDA

Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 35 of 200 · A–Z by INN

  1. ceftaroline fosamil

    ZINFORO

    INTRAVENOUS FDA: approved · EMA: approved

    J01DI02

  2. ceftazidime

    ZAVICEFTA

    INJECTION FDA: approved · EMA: approved

    J01DD52

  3. ceftazidime sodium

    FORTAZ IN PLASTIC CONTAINER

    INJECTION FDA: approved

  4. ceftazidime-avibactam

    NMPA: clinical trials

  5. ceftibuten dihydrate

    CEDAX

    ORAL FDA: approved

  6. ceftizoxime sodium

    CEFIZOX

    INJECTION FDA: approved

  7. ceftobiprole

    ZEFTERA (PREVIOUSLY ZEVTERA)

    EMA: refused

    J01DI01

  8. ceftobiprole medocaril sodium

    ZEVTERA

    INTRAVENOUS FDA: approved

  9. ceftolozane

    ZERBAXA

    EMA: approved

    J01DI54

  10. ceftolozane sulfate

    ZERBAXA

    INTRAVENOUS FDA: approved

  11. ceftriaxone

    CEFTRIAXONE VIATRIS Alphapharm Pty Ltd

    TGA: approved · NMPA: clinical trials

  12. ceftriaxone sodium

    CEFTRIAXONE Teva Pharma GmbH

    INJECTION FDA: approved

  13. cefuroxime

    PHARMACOR CEFUROXIME Lacuna Pharma Pty Ltd

    INJECTION FDA: approved · TGA: approved · NMPA: clinical trials

  14. cefuroxime axetil

    CEFTIN

    ORAL FDA: approved

  15. cefuroxime sodium

    CEFUROXIME SODIUM Teva Pharma GmbH

    INJECTION FDA: approved

  16. celecoxib

    APX-CELECOXIB Viatris Pharmaceuticals Co.,

    ORAL FDA: approved · EMA: withdrawn · TGA: approved

    L01XX33

  17. cell-derived

    NMPA: clinical trials

  18. cells

    NMPA: clinical trials

  19. cellulose sodium phosphate

    CALCIBIND

    ORAL FDA: approved

  20. cemiplimab

    LIBTAYO Lacuna Pharma Pty Ltd

    EMA: approved · TGA: approved · PMDA: approved

    L01XC33

  21. cemiplimab-rwlc

    LIBTAYO Regeneron UK Limited

    INTRAVENOUS FDA: approved

  22. cend-

    NMPA: clinical trials

  23. cenegermin

    OXERVATE

    EMA: approved

    S01

  24. cenegermin-bkbj

    OXERVATE

    OPHTHALMIC FDA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources